Table 1.
Phantomless QCT |
L1 ROI |
L3 ROI |
T12-L5ave ROI |
|
---|---|---|---|---|
Threshold for 100% sensitivity for osteoporosis | 90 mg/cc | 160 HU | 130 HU | 145 HU |
Sensitivity for osteoporosis | 100% (29/29) |
100% (29/29) |
100% (29/29) |
100% (29/29) |
Specificity for osteoporosis (at 100% sensitivity threshold)* |
63.8% (143/224) |
46.4% (104/224) |
54.0% (121/224) |
53.1% (119/224) |
% below threshold with low BMD at DXA** | 87.3% (96/110) |
83.9% (125/149) |
83.3% (110/132) |
84.3% (113/134) |
% above threshold with normal BMD*** | 49.6% (69/139) |
57.3% (59/103) |
50.8% (61/120) |
50.8% (61/120) |
Mean measurement (± SD) |
97.8 mg/cc (± 27.7 mg/cc) |
152.9 HU (± 38.3 HU) |
130.5 HU (± 38.6 HU) |
143.7 HU (± 36.7 HU) |
Measurement range | 28–178 mg/cc | 62–291 HU | 41–245 HU | 59–254 HU |
Mean patient age above/below threshold | 56.4 years/ 62.3 years |
55.7 years/ 61.2 years |
56.1 years/ 61.5 years |
56.1 years/ 61.5 years |
Mean patient BMI above/below threshold | 26.7 kg/m2/ 25.4 kg/m2 |
26.6 kg/m2/ 25.8 kg/m2 |
26.8 kg/m2/ 25.5 kg/m2 |
26.9 kg/m2/ 25.4 kg/m2 |
Patients with osteopenia per DXA below each threshold is considered a false positive result
Low BMD = osteoporosis or osteopenia
By definition, the remaining patients with low BMD above this threshold had only osteopenia at DXA – not osteoporosis